In short
Glycogen storage disease type V, also known as McArdle disease, requires careful evaluation to confirm the diagnosis and distinguish it from other muscle conditions. Understanding when to seek diagnostic testing and what methods doctors use can help patients receive proper care and management for this rare inherited muscle disorder.
Key points
- The "second wind" phenomenon—where muscle pain eases after brief rest and you can resume exercise—is a distinctive clue pointing toward McArdle disease rather than other muscle disorders.
- Genetic testing has become the preferred diagnostic method because it's accurate, non-invasive, and can identify the specific mutations in your family, requiring only a blood sample or cheek swab.
- The forearm exercise test reveals a telltale pattern: lactate levels remain flat while ammonia spikes during muscle work—the opposite of what happens in healthy muscles.
- Most people wait nearly 30 years between first symptoms and correct diagnosis, with 90% receiving at least one wrong diagnosis first, highlighting the importance of recognizing the distinctive symptom pattern.
- Dark or burgundy-colored urine after exercise signals dangerous muscle breakdown and requires immediate emergency medical attention to prevent kidney failure.
- Early diagnosis dramatically improves quality of life by allowing people to learn protective exercise strategies and dietary approaches before experiencing severe muscle damage.
- Scientists have identified 179 different mutations in the PYGM gene that can all cause McArdle disease, meaning each family may have a unique genetic variant of the condition.
- With proper management, most people with McArdle disease can live normal lifespans, though about half will experience at least one episode of muscle breakdown requiring medical care.
Introduction: Who Should Undergo Diagnostics
People who experience unusual muscle fatigue, cramping, or pain during physical activity should consider seeking medical evaluation, especially if these symptoms appear consistently during exercise and improve with rest. If you notice that your muscles become tired much faster than expected during activities like jogging, weight lifting, or even climbing stairs, this could signal a problem with how your muscles produce energy.
The challenge with glycogen storage disease type V is that symptoms often begin in childhood, but diagnosis typically happens much later in life. Many people first notice signs around age three, yet the average time between when symptoms start and when doctors make the correct diagnosis can stretch to 29 years. This lengthy delay occurs because symptoms can seem vague or be mistaken for other conditions. Approximately 90% of patients receive at least one incorrect diagnosis before the true cause is identified, and about 62% receive multiple wrong diagnoses.
You should seek diagnostic evaluation if you experience a characteristic pattern called the second wind phenomenon. This happens when you feel severe muscle pain and fatigue at the start of exercise, but after resting briefly and resuming activity, you can continue with much less discomfort. This distinctive pattern is an important clue that points toward McArdle disease rather than other muscle disorders.
Anyone who notices burgundy, red, or brown-colored urine after exercise should seek immediate medical attention. This color change indicates that muscle tissue is breaking down and releasing a protein called myoglobin into the bloodstream, which then appears in the urine. This condition, known as myoglobinuria, occurs in about half of people with glycogen storage disease type V and can lead to serious kidney damage if not addressed promptly.
Classic Diagnostic Methods
Diagnosing glycogen storage disease type V involves several different approaches, each providing specific information about how your muscles function and whether they can properly break down glycogen for energy. Doctors typically start with simpler tests and move toward more specialized examinations if initial results suggest a muscle metabolism problem.
Blood Tests
Blood tests serve as one of the first diagnostic tools doctors use when they suspect a muscle disorder. A particularly important blood test measures levels of an enzyme called creatine kinase (also called CK or CPK). When muscle cells are damaged, they release creatine kinase into the bloodstream, causing levels to rise significantly above normal. People with McArdle disease often show elevated creatine kinase levels, especially after physical activity. However, some individuals with this condition maintain normal creatine kinase levels between episodes of muscle breakdown, which can make diagnosis more challenging.
Doctors may also check blood levels of other substances that reveal how well muscles are working. These include lactate, ammonia, and uric acid. Understanding the pattern of these markers during and after exercise helps distinguish McArdle disease from other muscle conditions.
Exercise Testing
The nonischemic forearm exercise test represents a specialized diagnostic procedure specifically designed to identify problems with muscle energy metabolism. During this test, you squeeze a hand grip repeatedly while a blood pressure cuff on your upper arm remains inflated to a certain level. This causes your forearm muscles to work hard. Doctors then measure how levels of lactate and ammonia in your blood change during and after the exercise.
In people without McArdle disease, exercising muscles produce lactate as they break down glucose for energy, causing blood lactate levels to rise. However, individuals with glycogen storage disease type V cannot break down their stored glycogen into glucose, so their lactate levels remain flat or increase only minimally during the test. At the same time, ammonia levels typically rise more than expected. This distinctive pattern—low lactate with high ammonia after muscle exercise—strongly suggests McArdle disease.
Some medical centers also use more comprehensive exercise testing on specialized equipment. A 12-minute walk test or an exercise stress test on a treadmill or bicycle can measure your overall exercise capacity and heart rate response while monitoring for symptoms. These tests help doctors understand how severely the condition affects your daily functioning.
Muscle Biopsy
A muscle biopsy involves removing a small sample of muscle tissue, usually from the thigh, for detailed examination under a microscope. This procedure can directly show whether the enzyme myophosphorylase is present in muscle cells. In people with McArdle disease, special staining techniques reveal that myophosphorylase activity is absent or severely reduced. The biopsy may also show abnormal accumulation of glycogen within muscle fibers, appearing as clear spaces or vacuoles when viewed microscopically.
While muscle biopsy can provide definitive evidence of enzyme deficiency, it is an invasive procedure that requires a small surgical incision. Because of this, many doctors now prefer to use genetic testing first, reserving muscle biopsy for cases where genetic test results are unclear or unavailable.
Genetic Testing
Genetic testing has become the preferred method for confirming a diagnosis of glycogen storage disease type V. This test examines your DNA to look for mutations in the PYGM gene, which provides instructions for making the myophosphorylase enzyme. Scientists have identified 179 different variants of mutations in this gene that can cause McArdle disease. A blood sample or cheek swab is all that's needed to perform genetic testing.
The advantage of genetic testing is that it's non-invasive, highly accurate, and can identify the specific genetic changes causing the disease in your family. This information becomes valuable for family planning and for testing other family members who might carry the mutation. If genetic testing identifies two copies of mutated PYGM genes (one from each parent), the diagnosis is confirmed.
Imaging Studies
Advanced imaging techniques can provide additional information about muscle health and structure. Magnetic resonance imaging (MRI) of muscles can detect areas of muscle damage or abnormal signals that indicate problems with muscle metabolism. MRI is particularly useful for evaluating the extent of muscle involvement and tracking changes over time. Some specialized centers use MRI spectroscopy, which can measure chemical compounds within muscles and reveal metabolic abnormalities characteristic of McArdle disease.
Electromyography (EMG) is another diagnostic tool that measures the electrical activity of muscles. A doctor inserts thin needle electrodes into muscles to record their electrical patterns during rest and contraction. While EMG cannot diagnose McArdle disease specifically, it can help rule out other neuromuscular conditions and show patterns consistent with a metabolic muscle disorder.
Distinguishing McArdle Disease from Other Conditions
Several other medical conditions can cause exercise intolerance and muscle symptoms similar to McArdle disease, making accurate diagnosis essential. Other types of glycogen storage diseases affect muscles differently—for example, type III affects both liver and muscles, while type VII (Tarui disease) causes similar muscle symptoms but also affects red blood cells. Certain inflammatory muscle diseases, mitochondrial disorders, and other metabolic conditions can also mimic McArdle disease symptoms.
The combination of clinical history (especially the second wind phenomenon), characteristic blood test patterns during exercise, and confirmation through genetic testing or muscle biopsy allows doctors to distinguish McArdle disease from these other conditions with high accuracy. The specific pattern of low lactate production during forearm exercise testing is particularly distinctive for glycogen storage disease type V compared to other muscle disorders.
Diagnostics for Clinical Trial Qualification
When individuals with McArdle disease consider participating in clinical trials testing new treatments, they must undergo specific diagnostic evaluations to determine if they qualify for enrollment. Clinical trials use standardized criteria to ensure that all participants have confirmed diagnoses and that researchers can accurately measure whether experimental treatments work.
Genetic confirmation of McArdle disease through identification of two pathogenic mutations in the PYGM gene serves as the primary enrollment criterion for most clinical trials. This requirement ensures that participants truly have the condition being studied rather than a different muscle disorder with similar symptoms. Researchers need this certainty to properly interpret trial results.
Clinical trials typically require objective measurements of exercise capacity and muscle function at the beginning of the study to establish a baseline. Common measurements include the 12-minute walk test, which records how far you can walk in 12 minutes, or cycle ergometry tests that measure how long you can pedal at a specific workload. These standardized tests allow researchers to determine whether a treatment improves exercise tolerance compared to the starting point.
Blood tests measuring creatine kinase levels, lactate production, and other metabolic markers often serve as secondary outcome measures in trials. Researchers collect these measurements at regular intervals throughout the study to track biological changes that might indicate whether a treatment is affecting muscle metabolism. Some trials also use MRI scans to visualize changes in muscle tissue or to measure glycogen accumulation in muscles before and after treatment.
Quality of life questionnaires and symptom diaries represent important components of clinical trial assessments. These tools capture information about how treatments affect daily functioning, muscle pain, fatigue, and overall wellbeing—outcomes that matter most to people living with the condition. Standardized questionnaires ensure that researchers can compare results across different participants and different studies.
Prognosis and Survival Rate
Prognosis
The outlook for people with glycogen storage disease type V varies considerably depending on how effectively symptoms are managed. Many individuals can live normal lifespans with appropriate lifestyle modifications and proper management of their condition. The key to a favorable prognosis lies in learning to recognize your physical limitations, understanding the second wind phenomenon, and developing exercise habits that avoid triggering severe muscle breakdown.
Several factors influence long-term outcomes. Approximately 25% of people with McArdle disease develop permanent muscle weakness, which tends to affect the proximal muscles (those closest to the body's center, like hip and shoulder muscles) and becomes more common with advancing age. About half of individuals experience at least one episode of rhabdomyolysis during their lifetime, and among those who develop myoglobinuria, roughly half will experience life-threatening kidney failure.
The progression of muscle symptoms differs among individuals. In most people with McArdle disease, muscle weakness gradually worsens over time. However, about one-third of affected individuals maintain stable muscle function without progressive deterioration. Some people experience only mild symptoms such as reduced stamina, while others remain completely asymptomatic and may never know they have the genetic condition unless tested for other reasons.
Early and accurate diagnosis significantly improves prognosis by allowing individuals to adopt protective strategies before experiencing severe muscle damage. Those who learn proper warm-up techniques, understand how to exploit the second wind phenomenon, engage in appropriate regular exercise, and consume simple carbohydrates before physical activity can maintain better muscle health and quality of life over the long term. The prolonged diagnostic delays and multiple misdiagnoses that many patients experience can severely impact both physical and mental health, making timely diagnosis crucial for optimal outcomes.
Survival rate
Glycogen storage disease type V does not typically reduce life expectancy in most cases. People with this condition can live normal lifespans when they manage their diet and physical activity appropriately. The condition itself is not usually fatal, though serious complications can occur in specific circumstances.
The primary life-threatening risk comes from severe episodes of rhabdomyolysis leading to acute kidney failure. When extensive muscle breakdown occurs, myoglobin released from damaged muscles can overwhelm and damage the kidneys. However, with proper medical intervention and management, even these serious complications can often be treated successfully. Avoiding intense isometric exercise and maximal aerobic exertion helps prevent these dangerous episodes.
It's important to note that ultra-rare variants of the disease exist with different prognoses. An extremely rare fatal infantile-onset form causes profound muscle weakness and respiratory failure in infancy. Additionally, an ultra-rare adult-onset form presents very late in life (after age 70) with severe limb muscle wasting. However, these variants represent exceptional cases and differ substantially from the classic form of McArdle disease that affects most patients.
